Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Enterprise ValueMarket Capitalization

RAPT Therapeutics (RAPT) Return on Equity: 2020-2023

Historic Return on Equity for Therapeutics (RAPT) over the last 3 years, with Dec 2023 value amounting to -0.79%.

  • Therapeutics' Return on Equity fell 40.00% to -0.79% in Q4 2023 from the same period last year, while for Dec 2023 it was -0.79%, marking a year-over-year decrease of 40.00%. This contributed to the annual value of -0.65% for FY2023, which is 25.00% down from last year.
  • Therapeutics' Return on Equity amounted to -0.79% in Q4 2023, which was down 25.11% from -0.64% recorded in Q3 2023.
  • In the past 5 years, Therapeutics' Return on Equity ranged from a high of -0.31% in Q3 2021 and a low of -0.79% during Q4 2023.
  • In the last 3 years, Therapeutics' Return on Equity had a median value of -0.41% in 2022 and averaged -0.47%.
  • Per our database at Business Quant, Therapeutics' Return on Equity grew by 16bps in 2022 and then crashed by 40bps in 2023.
  • Quarterly analysis of 4 years shows Therapeutics' Return on Equity stood at -0.49% in 2020, then rose by 14bps to -0.36% in 2021, then decreased by 4bps to -0.39% in 2022, then tumbled by 40bps to -0.79% in 2023.
  • Its Return on Equity was -0.79% in Q4 2023, compared to -0.64% in Q3 2023 and -0.50% in Q2 2023.